The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Bayer/Onyx
Cellular heterogeneity during mouse pancreatic ductal adenocarcinoma progression at single-cell resolution.
 
Abdel Nasser Hosein
No Relationships to Disclose
 
Huocong Huang
No Relationships to Disclose
 
Zhaoning Wang
No Relationships to Disclose
 
Kamalpreet Parmar
No Relationships to Disclose
 
Wenting Du
No Relationships to Disclose
 
Jonathan Huang
No Relationships to Disclose
 
Anirban Maitra
Honoraria - Celgene
 
Eric Olson
No Relationships to Disclose
 
Udit Verma
No Relationships to Disclose
 
Rolf A. Brekken
Leadership - Tuevol Therapeutics
Stock and Other Ownership Interests - Regeneron
Consulting or Advisory Role - BerGenBio; Peregrine Pharmaceuticals; Synergys Biotherapeutics
Research Funding - BerGenBio; CellMid; Lilly; Lilly; Mirati Therapeutics; Oncologie; Peregrine Pharmaceuticals; Tolero Pharmaceuticals
Patents, Royalties, Other Intellectual Property - I am on multiple patents relevant to vascular targeting, VEGF inhibition and DDR1 inhibitors that have been licensed by companies from the University of Texas
Travel, Accommodations, Expenses - BerGenBio; Peregrine Pharmaceuticals